Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Sep 14, 2021 9:43pm
103 Views
Post# 33859805

RE:RE:RE:The Pathway to $ 9 !? - Corrected

RE:RE:RE:The Pathway to $ 9 !? - Corrected

Hey did you get your pretend 34 cent bid filled? seemed like more than enough to go around today. See if you can pretend to put more at a lower price. Maybe that will fill too while you STT and AP pretend you're different people circle jaying it.

Must feel weird complimenting yourself from different aliases pretending you're buying the stock and throwing out made up price targets. 

mercedesman wrote:

Accountprince wrote: Hi MM:

As always your calculations are spot on.  Since no value ascribed to Dialco and assuming it has about the same value as PMX you're using a discount factor of 50% for both.  Conservative given the advanced stages for both PMX and Dialco.  I've always had a conservative estimate of $8 to $10 per share for Spectral so your $9 per share value is exactly the midpoint.

All signs point to the share price being ready for a run from the pathetic $.32 per share to the ultimate FMV starting soon.  Should be exciting and rewarding.


Agreed AP.

The fact that they are mentioning "senior US Listing" more frequently now, suggests that perhaps, just maybe, we are getting closer to some real promotional efforts going forward.

While they may removed this as a "catalyst" , several Cdn Biotechs that I have been involved with, were able to see doubles in their share prices simply based on a formally announced "big-board" intent with timelines. 

Fingers crossed.  I doubt that the bought deal participants (US-based) are expecting anything less, having bought in at a price that is 25 % higher than today's SP.  Pretty sure they positioned for much better news flow and  much more liquidity in the short term...and perhaps even a US Analyst Report ;)

MM

PS:  devilishly difficult to secure more .34's but still managing to accumulate more.



<< Previous
Bullboard Posts
Next >>